Pfam Domains GO Terms
| TGF beta GS |
| Pkinase Tyr |
| Pkinase |
| Activin recp |
| regulation of tight junction disassembly |
| positive regulation of tight junction disassembly |
| epicardium morphogenesis |
| proepicardium development |
| septum transversum development |
| angiogenesis involved in coronary vascular morphogenesis |
| positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| parathyroid gland development |
| transforming growth factor beta receptor activity, type I |
| type II transforming growth factor beta receptor binding |
| activin receptor complex |
| regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| ventricular compact myocardium morphogenesis |
| positive regulation of cardiac epithelial to mesenchymal transition |
| coronary artery morphogenesis |
| germ cell migration |
| endothelial cell activation |
| regulation of cardiac epithelial to mesenchymal transition |
| I-SMAD binding |
| positive regulation of SMAD protein signal transduction |
| pathway-restricted SMAD protein phosphorylation |
| activin binding |
| transforming growth factor beta-activated receptor activity |
| ventricular trabecula myocardium morphogenesis |
| coronary vasculature morphogenesis |
| regulation of SMAD protein signal transduction |
| negative regulation of chondrocyte differentiation |
| transforming growth factor beta binding |
| activin receptor signaling pathway |
| response to cholesterol |
| pharyngeal system development |
| negative regulation of cartilage development |
| cardiac epithelial to mesenchymal transition |
| positive regulation of filopodium assembly |
| response to sterol |
| growth factor binding |
| heart trabecula morphogenesis |
| negative regulation of endothelial cell proliferation |
| regulation of cardiac muscle cell proliferation |
| regulation of heart morphogenesis |
| ventricular septum morphogenesis |
| thymus development |
| regulation of filopodium assembly |
| coronary vasculature development |
| trabecula morphogenesis |
| embryonic cranial skeleton morphogenesis |
| positive regulation of epithelial to mesenchymal transition |
| collagen fibril organization |
| ventricular cardiac muscle tissue morphogenesis |
| positive regulation of pathway-restricted SMAD protein phosphorylation |
| regulation of chondrocyte differentiation |
| positive regulation of stress fiber assembly |
| SMAD binding |
| activation of MAPKK activity |
| ventricular cardiac muscle tissue development |
| regulation of cardiac muscle tissue growth |
| positive regulation of actin filament bundle assembly |
| artery morphogenesis |
| regulation of pathway-restricted SMAD protein phosphorylation |
| regulation of heart growth |
| neuron fate commitment |
| endothelial cell migration |
| cranial skeletal system development |
| cardiac muscle tissue morphogenesis |
| epithelial to mesenchymal transition |
| regulation of cartilage development |
| ventricular septum development |
| cardiac septum morphogenesis |
| cardiac ventricle morphogenesis |
| negative regulation of transforming growth factor beta receptor signaling pathway |
| negative regulation of cellular response to transforming growth factor beta stimulus |
| lens development in camera-type eye |
| regulation of stress fiber assembly |
| regulation of cardiac muscle tissue development |
| muscle tissue morphogenesis |
| positive regulation of animal organ morphogenesis |
| peptidyl-threonine phosphorylation |
| regulation of epithelial to mesenchymal transition |
| epithelial cell migration |
| artery development |
| epithelium migration |
| muscle organ morphogenesis |
| post-embryonic development |
| regulation of actomyosin structure organization |
| roof of mouth development |
| peptidyl-threonine modification |
| regulation of actin filament bundle assembly |
| positive regulation of endothelial cell proliferation |
| tissue migration |
| regulation of organ growth |
| embryonic skeletal system morphogenesis |
| blastocyst development |
| positive regulation of plasma membrane bounded cell projection assembly |
| negative regulation of extrinsic apoptotic signaling pathway |
| transforming growth factor beta receptor signaling pathway |
| positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| cardiac septum development |
| regulation of transforming growth factor beta receptor signaling pathway |
| negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| regulation of cellular response to transforming growth factor beta stimulus |
| endocrine system development |
| bicellular tight junction |
| negative regulation of epithelial cell proliferation |
| embryonic skeletal system development |
| cardiac chamber morphogenesis |
| cardiac ventricle development |
| regulation of endothelial cell proliferation |
| regulation of striated muscle tissue development |
| male gonad development |
| regulation of muscle tissue development |
| development of primary male sexual characteristics |
| regulation of muscle organ development |
| cell cycle arrest |
| negative regulation of cellular response to growth factor stimulus |
| regulation of extrinsic apoptotic signaling pathway |
| cellular response to transforming growth factor beta stimulus |
| mesenchymal cell differentiation |
| male sex differentiation |
| response to transforming growth factor beta |
| cardiac muscle tissue development |
| positive regulation of cell growth |
| positive regulation of protein kinase B signaling |
| cardiac chamber development |
| ameboidal-type cell migration |
| positive regulation of apoptotic signaling pathway |
| peptidyl-serine phosphorylation |
| positive regulation of epithelial cell proliferation |
| positive regulation of supramolecular fiber organization |
| transmembrane receptor protein serine/threonine kinase signaling pathway |
| peptidyl-serine modification |
| regulation of protein ubiquitination |
| regulation of plasma membrane bounded cell projection assembly |
| regulation of cell projection assembly |
| receptor complex |
| gonad development |
| development of primary sexual characteristics |
| anterior/posterior pattern specification |
| regulation of protein binding |
| regulation of protein kinase B signaling |
| positive regulation of cytoskeleton organization |
| mesenchyme development |
| membrane raft |
| negative regulation of apoptotic signaling pathway |
| regulation of protein modification by small protein conjugation or removal |
| response to alcohol |
| regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| skeletal system morphogenesis |
| protein kinase activity |
| cell fate commitment |
| heart morphogenesis |
| regulation of animal organ morphogenesis |
| positive regulation of growth |
| regulation of actin filament organization |
| positive regulation of MAP kinase activity |
| sex differentiation |
| kidney development |
| endosome |
| regulation of cellular response to growth factor stimulus |
| protein deubiquitination |
| striated muscle tissue development |
| renal system development |
| embryonic organ morphogenesis |
| muscle organ development |
| muscle tissue development |
| protein modification by small protein removal |
| camera-type eye development |
| angiogenesis |
| urogenital system development |
| activation of protein kinase activity |
| regulation of developmental growth |
| regionalization |
| regulation of epithelial cell proliferation |
| positive regulation of protein serine/threonine kinase activity |
| extracellular matrix organization |
| regulation of MAP kinase activity |
| regulation of actin cytoskeleton organization |
| regulation of supramolecular fiber organization |
| cellular process involved in reproduction in multicellular organism |
| eye development |
| visual system development |
| protein serine/threonine kinase activity |
| sensory system development |
| regulation of binding |
| in utero embryonic development |
| positive regulation of cell projection organization |
| extracellular structure organization |
| regulation of actin filament-based process |
| regulation of apoptotic signaling pathway |
| blood vessel morphogenesis |
| gland development |
| regulation of cell growth |
| reproductive structure development |
| reproductive system development |
| embryonic organ development |
| pattern specification process |
| supramolecular fiber organization |
| muscle structure development |
| wound healing |
| blood vessel development |
| skeletal system development |
| positive regulation of cell migration |
| cellular response to growth factor stimulus |
| vasculature development |
| regulation of protein serine/threonine kinase activity |
| cardiovascular system development |
| positive regulation of cellular component biogenesis |
| positive regulation of cell motility |
| heart development |
| response to growth factor |
| positive regulation of protein kinase activity |
| positive regulation of cellular component movement |
| regulation of cytoskeleton organization |
| positive regulation of MAPK cascade |
| sensory organ development |
| positive regulation of locomotion |
| tissue morphogenesis |
| embryonic morphogenesis |
| response to wounding |
| negative regulation of cell cycle |
| positive regulation of kinase activity |
| hematopoietic or lymphoid organ development |
| cell surface |
| positive regulation of organelle organization |
| chordate embryonic development |
| positive regulation of apoptotic process |
| immune system development |
| positive regulation of programmed cell death |
| embryo development ending in birth or egg hatching |
| tube morphogenesis |
| positive regulation of transferase activity |
| developmental process involved in reproduction |
| regulation of growth |
| negative regulation of cell population proliferation |
| intracellular membrane-bounded organelle |
| gamete generation |
| regulation of plasma membrane bounded cell projection organization |
| positive regulation of cell death |
| regulation of cell projection organization |
| negative regulation of cell differentiation |
| enzyme linked receptor protein signaling pathway |
| regulation of MAPK cascade |
| regulation of protein kinase activity |
| multicellular organismal reproductive process |
| sexual reproduction |
| multicellular organism reproduction |
| tube development |
| regulation of cell migration |
| response to lipid |
| circulatory system development |
| regulation of kinase activity |
| peptidyl-amino acid modification |
| negative regulation of apoptotic process |
| anatomical structure formation involved in morphogenesis |
| negative regulation of programmed cell death |
| regulation of cell motility |
| positive regulation of cell population proliferation |
| response to organic cyclic compound |
| apoptotic process |
| negative regulation of developmental process |
| animal organ morphogenesis |
| regulation of cellular component biogenesis |
| cell migration |
| positive regulation of cell differentiation |
| protein phosphorylation |
| regulation of transferase activity |
| embryo development |
| regulation of locomotion |
| protein modification by small protein conjugation or removal |
| regulation of cellular component movement |
| negative regulation of cell death |
| multi-organism reproductive process |
| cell cycle process |
| neuron differentiation |
| positive regulation of protein phosphorylation |
| positive regulation of intracellular signal transduction |
| programmed cell death |
| positive regulation of phosphorylation |
| regulation of anatomical structure morphogenesis |
| cell activation |
| localization of cell |
| cell motility |
| cell death |
| positive regulation of phosphate metabolic process |
| positive regulation of phosphorus metabolic process |
| regulation of cell cycle |
| negative regulation of multicellular organismal process |
| positive regulation of cellular component organization |
| cellular response to endogenous stimulus |
| positive regulation of protein modification process |
| negative regulation of signal transduction |
| proteolysis |
| phosphorylation |
| regulation of organelle organization |
| locomotion |
| cell cycle |
| negative regulation of cell communication |
| negative regulation of signaling |
| positive regulation of developmental process |
| integral component of plasma membrane |
| reproductive process |
| reproduction |
| positive regulation of catalytic activity |
| regulation of protein phosphorylation |
| response to endogenous stimulus |
| ATP binding |
| generation of neurons |
| regulation of apoptotic process |
| positive regulation of transcription, DNA-templated |
| movement of cell or subcellular component |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| regulation of phosphorylation |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| neurogenesis |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| positive regulation of signal transduction |
| regulation of cell death |
| intracellular signal transduction |
| positive regulation of protein metabolic process |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| tissue development |
| positive regulation of molecular function |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| regulation of protein modification process |
| protein-containing complex subunit organization |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 1/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 1/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 1/29 |
| uterus | 0/5 |
Expression Distribution